Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Androgen receptor signaling pathway"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Heliyon, Vol 8, Iss 12, Pp e12114- (2022)
Objectives: Androgen deprivation therapy (ADT) is a standard treatment for advanced prostate cancer (PCa). However, after 2–3 years ADT treatment, prostate cancer inevitably transits from androgen-dependent PCa (ADPC) to androgen-independent PCa (A
Externí odkaz:
https://doaj.org/article/c1d6196bb4764b4abf98e03454312ec4
Autor:
Pengju Guo, Yongguang Jiang, Mingchuan Li, Jiahui Zhao, Qiankun Li, Dechao Wei, Yong Luo, Tao Feng, Xiaobing Yang
Publikováno v:
Exp Biol Med (Maywood)
Among many factors of causing castration-resistant prostate cancer (CRPC) progression, a growing number of evidences have shown androgen receptors play a critical role. Therefore, blocking androgen receptor remains a therapeutic goal of CRPC. However
Publikováno v:
Advances in Clinical and Experimental Medicine. 29:1153-1160
Background The post-translational modifications of proteins control various physiological and pathological events in cells. Objectives In this study, we investigated the influences of the X-linked deubiquitination enzyme USP26 in mediating androgen r
Autor:
Huijuan Song, Manlin Wang, Chunyu Wang, Chi Lv, Shengli Wang, Wei Liu, Wensu Liu, Xinping Zhong, Lin Lin, Kai Zeng, Shan Wei, Yue Zhao, Baosheng Zhou, Ning Sun
Publikováno v:
Cancer Science
Androgen receptor (AR) signaling is considered to be crucial for the pathogenesis of hepatocellular carcinoma (HCC) with obvious sexual dimorphism. Pre‐mRNA processing factor 6 (PRPF6) was identified as a coactivator of AR. However, the molecular m
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Haiping Ma, Tingting Cai, Jianping Xiu, Xin Kang, Tie Zhou, Li Zhang, Song Li, Shouyan Tang, Weidong Xu, Naping Zhao, Shen Gao, Jin Ni
Publikováno v:
The Prostate. 82(2)
BACKGROUND Preclinical studies showed that HC-1119, a deuterated version of enzalutamide, could competitively inhibit androgen binding to androgen receptor by blocking the transmission of androgen receptor signaling pathway as enzalutamide, inducing
Publikováno v:
Oncology Letters
The present study aimed to establish a mouse model of patient-derived castration-resistant prostate cancer (CRPC) xenograft tumors, and to evaluate the effects of various doses of metformin on phospholipase Ce (PLCe) expression and the neurogenic loc
Autor:
Yong Wu, Yong Peng, Guoxian Guan, Weizhong Jiang, Yiyi Zhang, Xing Liu, Yuanfeng Yang, Jinfu Zhuang, Qiao Gao
Publikováno v:
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
BackgroundTo identify the hub genes associated with chemoradiotherapy resistance in rectal cancer and explore the potential mechanism.MethodsWeighted gene co-expression network analysis (WGCNA) was performed to identify the gene modules correlated wi
Autor:
Dan Wang, Tian-Tian Liu, Chang Shi, Xiao-Hui Wu, Jiu-Xing Yan, Yan Cui, Zi-Jun Yang, Jialin Guo, Xue-Hui Zhu, Junzhang, Xin-Feng Zhou, Min Gong, Ying Li, Yan-Wen Zhang, Rongshan Li, Wei-Ting Wang
Publikováno v:
Analytical biochemistry. 642
Shen Gui capsule (SGC) has been demonstrated to have a significant treatment effect for coronary heart disease (CHD). Nevertheless, the holistic therapeutic mechanism of SGC in vivo remain poorly interpreted. We aimed to systematically explore the pr